Skip to main content
. 2022 Oct 5;12(1):111–119. doi: 10.4103/EUS-D-21-00187

Figure 2.

Figure 2

The number of enrolled patients with positive scores and the diagnosis rate for high-grade pancreatic precancerous lesion and invasive pancreatic cancer HGR, high-grade risk; IPMN: Intraductal papillary mucinous neoplasm; LGR: Low-grade risk; PanIN, pancreatic intraepithelial neoplasia